ABT-122
Sponsors
AbbVie
Conditions
Psoriatic ArthritisRheumatoid Arthritis
Phase 1
Phase 2
A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
CompletedNCT02141997
Start: 2014-07-31End: 2015-11-30Updated: 2016-11-11
A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)
CompletedNCT02349451
Start: 2015-04-28End: 2016-07-04Updated: 2017-08-04
A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197
TerminatedNCT02429895
Start: 2015-10-31End: 2016-05-31Updated: 2016-06-17
Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study
CompletedNCT02433340
Start: 2015-04-30End: 2016-05-31Updated: 2017-07-24